Tuesday, February 27, 2024

Workshop A 09.00 – 12.00

Enhancing Clinical Outcomes & Success Rates: Optimizing Phage Drug Development Platforms


With increased momentum in bacteriophage therapy, the industry is anticipating substantial updates in clinical results which will be the defining moment. However, this is easier said than done. With the complexity of clinical trial design, regulatory requirements, and patient recruitment, we will utilize this interactive workshop to give you hands-on guidance on designing and preparing for a bacteriophage clinical trial that supports pipeline progression. Join this 3-hour session and learn how to:

  • Construct ‘artificial patient’ models in the lab to discover rare phage for better outcomes
  • Combine in vitro, in vivo, and eIND data for clinical translatability
  • Develop complex study designs to improve clinical results

Workshop B 1.00 – 4.00

Tailored Fundraising & Business Model for Bacteriophage Therapy Development & Commercial Viability


Bacteriophage therapy has lucrative potentials but funding, market access, and sustainable profitability will require a new playbook compared to traditional drug development approaches.

Join this 3-hour session and learn how to:

  • Identify funding opportunities that are personalized for your business at early-stage phage therapy development
  • Secure adequate funding for R&D as well as commercialization of clinical trial outcomes
  • Define executable market access strategies and establish collaborations for driving phage therapy opportunities forward